A BMI of 27 or higher (overweight) with conditions like high blood pressure, type 2 diabetes, or high cholesterol
doi: 10.3389/fimmu.2026.1845654 Received 02 April 2026 Revised 07 April 2026 Accepted 21 April 2026 Published 11 May 2026 Volume 17 - 2026 Edited by Venkata Ramireddy Narala, Yogi Vemana University, India Reviewed by Farrah Kheradmand, Baylor College of Medicine, United States Homayon Ghiasi, Cedars Sinai Medical Center, United States Updates Copyright 2026 Cain, Hurrell, Shen, Speliakos and Akbari
Naltrexone-bupropion (Contrave) primarily causes nausea rather than diarrhea, affecting approximately 30% of users initially
The development of an effective oral GLP-1 receptor agonist is groundbreaking and less established compared to the injectable forms
According to ASPS 2026 trend statistics, fat transfer is an important part of several GLP-1 makeover operations
We aim to hasten the transformation of sick care to true health care, to replace one-size-fits-all disease management with personalized, preventive medicine
